login
login

Europe Daily Bulletin No. 13013

3 September 2022
Contents Publication in full By article 14 / 19
EU RESPONSE TO COVID-19 / Health
European Commission gives green light to first vaccines adapted to SARS-CoV-2 sub-variant of concern

02/09/2022 (Agence Europe)On Thursday 1 September, the European Commission granted conditional marketing authorisation for two SARS-CoV 2 vaccines adapted to the original virus and the BA.1 sub-variant.

These were a vaccine developed by PfizerBioNTech and another one developed by Moderna(see EUROPE B13012A23), both of which had been recommended a few hours earlier by the European Medicines Agency. Commissioner for Health Stella Kyriakides pointed out that the PfizerBioNTech and Moderna...

Contents

Russian invasion of Ukraine
SECTORAL POLICIES
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
SOCIAL AFFAIRS
NEWS BRIEFS